Sökning: "hematological malignancy"
Visar resultat 1 - 5 av 24 avhandlingar innehållade orden hematological malignancy.
1. Coagulase-negative staphylococci in hematological malignancy
Sammanfattning : Bacterial infections are common in hematological malignancy. Coagulase-negative staphylococci (CoNS) are among the most prevalent causes of bacteremia in patients with hematological malignancies. LÄS MER
2. Genetic studies of susceptibility to inflammation, autoimmunity, and hematological malignancy
Sammanfattning : The immune system represents the body’s defense against infectious organisms. Inborn defects of the immune system, called primary immunodeficiencies (PIDs), are a heterogeneous group of Mendelian disorders. Clinically, PIDs can cause isolated to broad susceptibility to pathogens, severe hyperinflammation, autoimmunity, allergy, and cancer. LÄS MER
3. Neutropenic fever during treatment of hematological malignancy : etiology and diagnostics
Sammanfattning : Fever is the principal and sometimes the only manifestation of serious infection in the neutropenic patient because signs of inflammation may be minimal or absent in this group of patients. The aim of this thesis was to improve the clinical management of the febrile neutropenic patient. LÄS MER
4. Viral infections in immunosuppressed patients with hematological malignancies
Sammanfattning : Acute or reactivated viral infections are common in patients who are immunosuppressed because of hematopoietic stem cell transplantation (HSCT) or chemotherapy due to hematological malignancies. The severity of the immunosuppression, the type of immune functions that are affected by various therapeutic interventions, as well as underlying hematological malignancy contributes to viral susceptibility and clinical outcome of the infection. LÄS MER
5. Comorbidity in risk and outcome of hematological malignancies
Sammanfattning : Hematological malignancies are a group of neoplasms that originate from the bone marrow or lymphatic tissues representing close to 10% of the overall cancer burden in the world. Clinical course, prognosis and survival varies greatly from very aggressive disease requiring intensive systemic chemotherapy-based treatment to indolent forms without need of therapy at diagnosis. LÄS MER